Everolimus (Standard) | MedChemExpress (MCE)
Everolimus (Standard) is the analytical standard of Everolimus. This product is intended for research and analytical applications. Everolimus (RAD001) is a Rapamycin (HY-10219) derivative and a potent, selective and orally active mTOR1 inhibitor. Everolimus binds to FKBP-12 to generate an immunosuppressive complex. Everolimus inhibits tumor cells proliferation and induces cell apoptosis and autophagy. Everolimus has potent immunosuppressive and anticancer activities[1][2].
| Trivial name | Everolimus (Standard) |
| Catalog Number | HY-10218R |
| Alternative Name(s) | RAD001 (Standard); SDZ-RAD (Standard) |
| Research Area | Cancer |
| CAS# | 159351-69-6 |
| Purity | ≥98.0% |
| SMILES | O=C([C@@]1(O)[C@@H](CC[C@@H](C[C@@H](/C(C)=C/C=C/C=C/[C@H](C[C@@H](C)C([C@@H]([C@@H](/C(C)=C/[C@H]2C)O)OC)=O)C)OC)O1)C)C(N3CCCC[C@H]3C(O[C@@H](CC2=O)[C@@H](C[C@H]4C[C@H]([C@H](OCCO)CC4)OC)C)=O)=O |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/everolimus-standard.html |